检索结果 - Denise Sutherland‐Phillips

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America

    First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America 由 Benjamin Young, Kathleen Squires, Parul Patel, Edwin DeJesus, Nicholaos Bellos, Daniel Berger, Denise Sutherland‐Phillips, Qiming Liao, Mark S. Shaefer, Paul Wannamaker

    出版 2008
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment

    Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment 由 Kimberly Y. Smith, Parul Patel, Derek M. Fine, Nicholaos Bellos, Louis Sloan, Philip Lackey, Princy Kumar, Denise Sutherland‐Phillips, Cindy Vavro, Linda Yau, Paul Wannamaker, Mark S. Shaefer

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    High Sensitivity of Human Leukocyte Antigen–B*5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients

    High Sensitivity of Human Leukocyte Antigen–B*5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients 由 Michael S. Saag, Rukmini Balu, Elizabeth J. Phillips, Philip S. Brachman, Claudia Martorell, William J. Burman, Britt Stancil, Michael Mosteller, Cindy Brothers, Paul Wannamaker, Arlene R. Hughes, Denise Sutherland‐Phillips, S. Mallal, Mark S. Shaefer

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: